Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cancer Research UK Phase I/IIa Clinical Trial of BT1718, (A Bicycle Drug Conjugate) Given Intravenously in Patients with Advanced Solid Tumours.

NCT03486730 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT03486730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03486730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cancer Research UK Phase I/IIa Clinical Trial of BT1718, (A Bicycle Drug Conjugate) Given Intravenously in Patients with Advanced Solid Tumours.
Lead sponsor
Cancer Research UK
Phase
Phase 1/2
Overall status
Completed
Start date
January 24, 2018
Completion date
November 20, 2023
Enrollment
72 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumours, non-small cell lung cancer, non-small cell lung sarcoma, oesophageal cancer